glp 1 discontinuation rates November Blog Trajectory of weight regain after

Ozempic received FDA approval in 2017 specifically for improving blood sugar control in adults with Type 2 diabetes

(2021) Medium-chain triglycerides inhibit long-chain triglyceride-induced GIP secretion through GPR120-dependent inhibition of CCK

For consumers with insurance coverage, medication costs may be as low as a copay amount determined by the insurance plan

There are many different eye diseases

[13] [14] Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not receive GLP-1 medications due to the theoretical risk of thyroid C-cell tumors